A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
K2 Medical Research
Clinical research site in Tampa, Florida · 1419 W WATERS AVE, SUITE 115, TAMPA, FL 33604-2895 · (813) 810-2119 · Website
Part of K2 Medical Research
As of July 2026, 11 paid clinical trials are recruiting at K2 Medical Research in Tampa, Florida. Active studies at this site cover conditions such as Alcohol Use Disorder, Alzheimer Disease and Dementia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at K2 Medical Research (11)
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for Major Depressive Episode (MDE)
25 locations incl. Phoenix
Sponsor: Tonix Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07621237·Phase 2·Recruiting·Listed Jun 2, 2026
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
26 locations incl. Little Rock
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for Depressive Disorder, Major
32 locations incl. Moorpark
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07412756·Phase 3·Recruiting·Listed Feb 2026
A Study of Brenipatide in Participants With Alcohol Use Disorder
for Alcohol Use Disorder
29 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219953·Phase 3·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for Alcohol Use Disorder
30 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219966·Phase 3·Recruiting·Listed Oct 2025
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
for Early Alzheimer's Disease
36 locations incl. Irvine
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 50 - 85
Code: NCT07033494·Phase 2·Recruiting·Listed Jun 2025
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
for Major Depressive Disorder
43 locations incl. Phoenix
Sponsor: Cybin IRL Limited
Sex: All·Age: 18 - 85
Code: NCT06564818·Phase 3·Recruiting·Listed Aug 2024
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for Treatment Resistant Depression
53 locations incl. Birmingham
Sponsor: LivaNova
Sex: All·Age: 18+
Code: NCT03887715·Recruiting·Listed Mar 2019
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
for Vitiligo
18 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07533019·Phase 2·Recruiting·Listed Apr 2026
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
for Alzheimer Disease
11 locations incl. Los Alamitos
Sponsor: Eli Lilly and Company
Sex: All·Age: 45 - 85·Accepts healthy volunteers
Code: NCT06657768·Phase 1·Recruiting·Listed Oct 2024
More research sites in Tampa
- Moffitt Cancer Center (267 trials)
- University of South Florida (118 trials)
- Tampa General Hospital (66 trials)
- Saint Joseph's Hospital/Children's Hospital-Tampa (37 trials)
- Moffitt Cancer Center - McKinley Campus (26 trials)
- Moffitt Cancer Center-International Plaza (22 trials)
- Moffit Cancer Center (13 trials)
- K2 Medical Research - Tampa (8 trials)
- St. Joseph's Children's Hospital (8 trials)
- USF Health (8 trials)